175 related articles for article (PubMed ID: 30807551)
1. Formylated honokiol analogs showed antitumor activity against lung carcinoma.
Deng S; Zhang C; Yang L; Ma L
Anticancer Drugs; 2019 Sep; 30(8):795-802. PubMed ID: 30807551
[TBL] [Abstract][Full Text] [Related]
2. Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer.
Tang H; Zhang Y; Li D; Fu S; Tang M; Wan L; Chen K; Liu Z; Xue L; Peng A; Ye H; Chen L
Eur J Med Chem; 2018 Aug; 156():190-205. PubMed ID: 30006164
[TBL] [Abstract][Full Text] [Related]
3. Liposomal honokiol inhibits VEGF-D-induced lymphangiogenesis and metastasis in xenograft tumor model.
Wen J; Fu AF; Chen LJ; Xie XJ; Yang GL; Chen XC; Wang YS; Li J; Chen P; Tang MH; Shao XM; Lu Y; Zhao X; Wei YQ
Int J Cancer; 2009 Jun; 124(11):2709-18. PubMed ID: 19219913
[TBL] [Abstract][Full Text] [Related]
4. Structural modification of honokiol, a biphenyl occurring in Magnolia officinalis: the evaluation of honokiol analogues as inhibitors of angiogenesis and for their cytotoxicity and structure-activity relationship.
Ma L; Chen J; Wang X; Liang X; Luo Y; Zhu W; Wang T; Peng M; Li S; Jie S; Peng A; Wei Y; Chen L
J Med Chem; 2011 Oct; 54(19):6469-81. PubMed ID: 21853991
[TBL] [Abstract][Full Text] [Related]
5. Novel histone deacetylase inhibitors derived from Magnolia officinalis significantly enhance TRAIL-induced apoptosis in non-small cell lung cancer.
Liu Y; Tong Y; Yang X; Li F; Zheng L; Liu W; Wu J; Ou R; Zhang G; Hu M; Liu Z; Lu L
Pharmacol Res; 2016 Sep; 111():113-125. PubMed ID: 27268146
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of new compounds bearing 3-(4-aminopiperidin-1-yl)methyl magnolol scaffold as anticancer agents for the treatment of non-small cell lung cancer via targeting autophagy.
Zhao M; Zheng YH; Zhao QY; Zheng W; Yang JH; Pei HY; Liu L; Liu KJ; Xue LL; Deng DX; Wang L; Ma X; Fu SH; Peng AH; Tang MH; Luo YZ; Ye HY; Chen LJ
Eur J Med Chem; 2021 Jan; 209():112922. PubMed ID: 33069436
[TBL] [Abstract][Full Text] [Related]
7. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.
Huang KJ; Kuo CH; Chen SH; Lin CY; Lee YR
J Cell Mol Med; 2018 Mar; 22(3):1894-1908. PubMed ID: 29363886
[TBL] [Abstract][Full Text] [Related]
8. Liposomal honokiol, a potent anti-angiogenesis agent, in combination with radiotherapy produces a synergistic antitumor efficacy without increasing toxicity.
Hu J; Chen LJ; Liu L; Chen X; Chen PL; Yang G; Hou WL; Tang MH; Zhang F; Wang XH; Zhao X; Wei YQ
Exp Mol Med; 2008 Dec; 40(6):617-28. PubMed ID: 19116447
[TBL] [Abstract][Full Text] [Related]
9. A novel honokiol liposome: formulation, pharmacokinetics, and antitumor studies.
Zhou C; Guo C; Li W; Zhao J; Yang Q; Tan T; Wan Z; Dong J; Song X; Gong T
Drug Dev Ind Pharm; 2018 Dec; 44(12):2005-2012. PubMed ID: 30058387
[TBL] [Abstract][Full Text] [Related]
10. Honokiol: a potent chemotherapy candidate for human colorectal carcinoma.
Chen F; Wang T; Wu YF; Gu Y; Xu XL; Zheng S; Hu X
World J Gastroenterol; 2004 Dec; 10(23):3459-63. PubMed ID: 15526365
[TBL] [Abstract][Full Text] [Related]
11. Improved therapeutic efficacy against murine carcinoma by combining honokiol with gene therapy of PNAS-4, a novel pro-apoptotic gene.
Yuan Z; Liu H; Yan F; Wang Y; Gou L; Nie C; Ding Z; Lai S; Zhao Y; Zhao X; Li J; Deng H; Mao Y; Chen L; Wei Y; Zhao X
Cancer Sci; 2009 Sep; 100(9):1757-66. PubMed ID: 19575751
[TBL] [Abstract][Full Text] [Related]
12. Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model.
Jiang QQ; Fan LY; Yang GL; Guo WH; Hou WL; Chen LJ; Wei YQ
BMC Cancer; 2008 Aug; 8():242. PubMed ID: 18706101
[TBL] [Abstract][Full Text] [Related]
13. In vitro growth inhibition of human cancer cells by novel honokiol analogs.
Lin JM; Prakasha Gowda AS; Sharma AK; Amin S
Bioorg Med Chem; 2012 May; 20(10):3202-11. PubMed ID: 22533983
[TBL] [Abstract][Full Text] [Related]
14. Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models.
Hou W; Chen L; Yang G; Zhou H; Jiang Q; Zhong Z; Hu J; Chen X; Wang X; Yuan Y; Tang M; Wen J; Wei Y
Phytother Res; 2008 Aug; 22(8):1125-32. PubMed ID: 18570244
[TBL] [Abstract][Full Text] [Related]
15. Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors.
Song JM; Anandharaj A; Upadhyaya P; Kirtane AR; Kim JH; Hong KH; Panyam J; Kassie F
Oncotarget; 2016 Sep; 7(36):57752-57769. PubMed ID: 27458163
[TBL] [Abstract][Full Text] [Related]
16. Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis.
Zhang Q; Zhao W; Ye C; Zhuang J; Chang C; Li Y; Huang X; Shen L; Li Y; Cui Y; Song J; Shen B; Eliaz I; Huang R; Ying H; Guo H; Yan J
Oncotarget; 2015 Nov; 6(35):37335-48. PubMed ID: 26484567
[TBL] [Abstract][Full Text] [Related]
17. Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction.
Hahm ER; Arlotti JA; Marynowski SW; Singh SV
Clin Cancer Res; 2008 Feb; 14(4):1248-57. PubMed ID: 18281560
[TBL] [Abstract][Full Text] [Related]
18. Antineoplastic Effects of Honokiol on Melanoma.
Guillermo-Lagae R; Santha S; Thomas M; Zoelle E; Stevens J; Kaushik RS; Dwivedi C
Biomed Res Int; 2017; 2017():5496398. PubMed ID: 28194418
[TBL] [Abstract][Full Text] [Related]
19. Magnolol Inhibits the Growth of Non-Small Cell Lung Cancer via Inhibiting Microtubule Polymerization.
Shen J; Ma H; Zhang T; Liu H; Yu L; Li G; Li H; Hu M
Cell Physiol Biochem; 2017; 42(5):1789-1801. PubMed ID: 28746938
[TBL] [Abstract][Full Text] [Related]
20. Semi-synthesis and anti-proliferative activity evaluation of novel analogues of Honokiol.
Luo Y; Xu Y; Chen L; Hu J; Peng C; Xie D; Shi J; Huang W; Xu G; Peng M; Han J; Li R; Yang S; Wei Y
Bioorg Med Chem Lett; 2009 Aug; 19(16):4702-5. PubMed ID: 19589678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
